Abbott, Alere, Roche, and Others Receive FDA Clearances in May

Jun 08, 2018

|

NEW YORK (360Dx) – Abbott, its subsidiary Alere, and Roche were among companies that received US Food and Drug Administration clearances in May for their in vitro diagnostic tests, according to the FDA website.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Abbott, Alere, Roche, and Others Receive FDA Clearances in May

To read the full story....

Breaking News

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

Siemens Healthineers Q1 Diagnostics Revenues Rise 17 Percent on Pandemic-Related Demand

Abbott Panbio SARS-CoV-2 Rapid Antigen Test Nabs CE Mark for Asymptomatic Screening, Self-Collection

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Featured White Papers

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

What's Popular?

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Infectious Disease Test Firm Talis Biomedical Files for IPO

Siemens Healthineers Q1 Diagnostics Revenues Rise 17 Percent on Pandemic-Related Demand

Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets

Lab Stakeholders Welcome Biden Moves on COVID-19 Testing, Suggest Additional Steps

Sponsorships